Niramai Health Analytix, a Deeptech health startup raised research funding from impact investor CDC for NIRAMAI FeverTest, which was launched last year.
With leveraging of computer vision and AI to analyze and monitor crowd compliance to COVID-19 guidelines, NIRAMAI FeverTest’s smart software enables screening for COVID-19 symptoms in public places.
- Read more about AI based start-up Niramai raised funding from CDC group
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/ai-based-start-up-niramai-raised-funding-from-cdc-group
No comments:
Post a Comment